Nuvaxovid
COVID-19 Vaccine (recombinant, adjuvanted)
COVID-19 virus infection
Date of authorisation:
Revision: 12
Last updated:
MedicineHumanAuthorised
EMEA-002941-PIP01-20-M02 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Vaccines
PIP number: P/0250/2022
Route(s) of administration: Intramuscular use
Pharmaceutical form(s):
Suspension for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Xalkori
crizotinib
Carcinoma, Non-Small-Cell Lung
Date of authorisation:
Revision: 33
Last updated:
MedicineHumanAuthorised
EMEA-001493-PIP03-18-M01 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Oncology
PIP number: P/0036/2021
Route(s) of administration: Oral use
Pharmaceutical form(s):
Capsule (hard)
Age-appropriate oral dosage form
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-001493-PIP02-18 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Oncology
PIP number: P/0361/2018
Route(s) of administration: Oral use
Pharmaceutical form(s):
Capsule (hard)
Decision date:
Last updated:
Compliance check: ✖
PIPHuman